Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival.

Irmer B, Wlochowitz D, Krekeler C, Richter KM, Chandrabalan S, Bayerlova M, Wolff A, Lenz G, Conradi LC, Schildhaus HU, Stadelmann C, Rohde V, Proescholdt M, Salinas G, Homayounfar K, Kuhlmann T, Hailfinger S, Pukrop T, Menck K, Beissbarth T, Bleckmann A

Open source

DOI: 10.1002/1878-0261.13748
Published: 2025 Mar
Container: Molecular oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/1878-0261.13748,
  title = {Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival.},
  author = {Irmer B and Wlochowitz D and Krekeler C and Richter KM and Chandrabalan S and Bayerlova M and Wolff A and Lenz G and Conradi LC and Schildhaus HU and Stadelmann C and Rohde V and Proescholdt M and Salinas G and Homayounfar K and Kuhlmann T and Hailfinger S and Pukrop T and Menck K and Beissbarth T and Bleckmann A},
  year = {2025},
  journal = {Molecular oncology},
  doi = {10.1002/1878-0261.13748},
  url = {https://doi.org/10.1002/1878-0261.13748}
}

RIS

TY  - JOUR
TI  - Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival.
AU  - Irmer B
AU  - Wlochowitz D
AU  - Krekeler C
AU  - Richter KM
AU  - Chandrabalan S
AU  - Bayerlova M
AU  - Wolff A
AU  - Lenz G
AU  - Conradi LC
AU  - Schildhaus HU
AU  - Stadelmann C
AU  - Rohde V
AU  - Proescholdt M
AU  - Salinas G
AU  - Homayounfar K
AU  - Kuhlmann T
AU  - Hailfinger S
AU  - Pukrop T
AU  - Menck K
AU  - Beissbarth T
AU  - Bleckmann A
PY  - 2025
JO  - Molecular oncology
DO  - 10.1002/1878-0261.13748
UR  - https://doi.org/10.1002/1878-0261.13748
ER  -

APA

B, I., D, W., C, K., KM, R., S, C., M, B., A, W., G, L., LC, C., HU, S., C, S., V, R., M, P., G, S., K, H., T, K., S, H., T, P., K, M., T, B., & A, B. (2025). Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival.. Molecular oncology. https://doi.org/10.1002/1878-0261.13748

Source records

pubmed · retrieved 2026-09-26T08:44:04.932Z